N. DERİCİOĞLU Et Al. , "Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience," CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5, pp.345-350, 2021
DERİCİOĞLU, N. Et Al. 2021. Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience. CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5 , 345-350.
DERİCİOĞLU, N., ARSLAN, D., ARSAVA, E. M., & TOPÇUOĞLU, M. A., (2021). Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience. CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5, 345-350.
DERİCİOĞLU, NEŞE Et Al. "Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience," CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5, 345-350, 2021
DERİCİOĞLU, NEŞE Et Al. "Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience." CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5, pp.345-350, 2021
DERİCİOĞLU, N. Et Al. (2021) . "Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience." CLINICAL EEG AND NEUROSCIENCE , vol.52, no.5, pp.345-350.
@article{article, author={NEŞE DERİCİOĞLU Et Al. }, title={Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience}, journal={CLINICAL EEG AND NEUROSCIENCE}, year=2021, pages={345-350} }